MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
38.05
+1.70 (4.68%)
At close: Apr 2, 2025, 4:00 PM
37.00
-1.05 (-2.76%)
After-hours: Apr 2, 2025, 7:33 PM EDT

MLTX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-118.94-36.01-49.97-64.37
Depreciation & Amortization
1.380.370.160.01
Asset Writedown & Restructuring Costs
---5.82
Stock-Based Compensation
7.287.119.6510.86
Other Operating Activities
-2.53-8.03-14.160.09
Change in Accounts Receivable
-1.79-0.84-0.07-0.18
Change in Accounts Payable
7.151.58-1.311.88
Change in Other Net Operating Assets
-9.15-6.96-0.23.68
Operating Cash Flow
-116.59-42.78-55.89-42.21
Capital Expenditures
-0.52-0.28-0.02-0.06
Investment in Securities
-205.08-24.9-32.32-
Investing Cash Flow
-205.6-25.18-32.34-0.06
Total Debt Issued
---18
Short-Term Debt Repaid
---15-
Total Debt Repaid
---15-
Net Debt Issued (Repaid)
---1518
Issuance of Common Stock
52.78482.450.050.13
Repurchase of Common Stock
-0---0.01
Other Financing Activities
-1.47-2.75134.65-
Financing Cash Flow
51.31479.7119.6951.92
Foreign Exchange Rate Adjustments
0.13-0.080.010
Net Cash Flow
-270.74411.6631.479.65
Free Cash Flow
-117.11-43.06-55.91-42.27
Free Cash Flow Per Share
-1.86-0.88-1.90-5.39
Cash Income Tax Paid
0.150.040-
Levered Free Cash Flow
-92.06-24.14-32.23-
Unlevered Free Cash Flow
-92.06-24.14-32.23-
Change in Net Working Capital
10.78-2.491.37-
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q